First Disease-Specific Stem Cell Line by SCNT
A team of scientists led by the NYSCF Research Institute’s Dr. Dieter Egli report the first ever patient-specific, diploid (i.e. with two sets of chromosomes, the...
64 Results
Clear Filters
Scientists Upend 160 Years of Neuroanatomy With New Finding
NYSCF – Robertson Stem Cell Investigator Dr. Paola Arlotta, of Harvard University, has made an exciting breakthough and paradigm shift in the basic understanding of neuroanatomy....
Stem Cell Therapy Treatment for Multiple Sclerosis Approved by FDA for Stage I Clinical Trial
In an exciting new development, the Food and Drug Administration (FDA) has approved a new stem cell-derived treatment for a phase I clinical trial in the...
Shining a Light on MS: NYSCF Investigator Profiled
Multiple Sclerosis Discovery Forum followed NYSCF — Helmsley Investigator Valentina Fossati, PhD, on her quest that is as scientific as personal. When she turned 30, Fossati was diagnosed...
NYSCF Investigators Generate New Cells to Study Multiple Sclerosis: A Conversation with Paul Tesar and Marius Wernig
At our annual Innovator's retreat, our 2010 NYSCF — Robertson Stem Cell Investigators Paul Tesar, PhD, of Case Western University, and Marius Wernig, MD, PhD, of...
Skin Cells Transformed to Repair Multiple Sclerosis Damage
Multiple sclerosis, an autoimmune disease in which immune cells attack the fatty protective layer of myelin cells, may have a potential treatment. Through stem cell techniques,...
Dr. Fossati’s Work Opens a Window into MS
Dr. Valentina Fossati conducts research in The New York Stem Cell Foundation Laboratory to unlock the mysteries of multiple sclerosis (MS), a disease that affects...
Winter Research Update
Four NYSCF-supported researchers published exciting new research in major scientific journals this fall. In the November 6th issue of Nature, Jae-won Shim, PhD, a NYSCF –...
Multiple Sclerosis Research Center of New York Announces Clinical Trial for Multiple Sclerosis
11/21/11 The Multiple Sclerosis Research Center of New York (MSRCNY) and the International Cellular Medicine Society (ICMS) jointly announced today the ICMS Institutional Review Board’s (IRB)...
Susan L. Solomon to Speak on ‘State of Industry’ of Regenerative Medicine at Biotech Showcase in San Francisco
Susan L. Solomon to Speak on ‘State of Industry’ of Regenerative Medicine at Biotech Showcase in San Francisco NEW YORK, NY (January 9, 2012) – Susan L....
NYSCF – Robertson Investigator Paul Tesar Creates Cells That Die in Multiple Sclerosis
NYSCF – Robertson Investigator, Dr. Paul Tesar of Case Western Reserve University, published in Nature Methods today that they have succesfully produced the myelinating cells that...
Dr. Paul Tesar on Becoming a Scientist, his Research Goals, and his Newly Published Work
For the second in our series of researcher interviews, we bring you some thoughts from Dr. Paul Tesar, a member of the inaugural class of NYSCF...
Stem cell transplants show promise for MS: study
Reuters “CHICAGO (Reuters) – U.S. researchers have reversed multiple sclerosis symptoms in early stage patients by using bone marrow stem cell transplants to reset the immune...
NYSCF Responds to New Jersey Stem Cell Vote
The New York Stem Cell Foundation expresses its disappointment in the state of New Jersey for voting “no” on the Stem Cell Research Bond Act ballot...